Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the must-buy penny stocks to invest in now. Recursion Pharmaceuticals ...

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the best medical AI stocks to buy now. On March 31, Recursion moved to ...

With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.60, marking a -4% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.26%.

As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiff Oncology , Revolution Medicines and Legend Biotech with bullish sentiments ...

Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...

A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled “Toward actionable interventions in ...

You can bring initial model predictions closer to reality by training those AI models on rich patient data. The more detailed ...